Results 221 to 230 of about 19,002,199 (367)

Multi-functional role of apolipoprotein E in neurodegenerative diseases. [PDF]

Front Aging Neurosci
Islam S, Noorani A, Sun Y, Michikawa M, Zou K.   +4 more
europepmc   +1 more source

GREM1 deficiency induced bone marrow adipose niche promotes B‐cell acute lymphoblastic leukemia disease progression

International Journal of Cancer, EarlyView.
What's New? Too often, children treated for B‐cell acute lymphocytic leukemia (B‐ALL) experience relapse. Here, the authors investigate the role of dyslipidemia in leukemia progression. Higher adipogenicity in bone marrow mesenchymal stem cells, and increased triglyceride accumulation, are associated with higher risk of death.
Lili Song, Rui Zhang, Liya Pan, Qiang Mi, Yi Yang, Xiang Wang, Yani Ma, Shuhong Shen, Benshang Li, Yanxin Li, Li Hong   +10 more
wiley   +1 more source

Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

, 1994
S H Zhang, R L Reddick, B Burkey, N Maeda   +3 more
openalex   +2 more sources

Sex‐specific associations of Roseburia with uric acid metabolism and hyperuricemia risk in females

iMetaOmics, EarlyView.
Researchers recruited 623 participants, including 270 females, and used 16S rDNA sequencing to investigate gender differences in hyperuricemia. In healthy females, Roseburia was enriched, positively correlating with estrogen and negatively with uric acid, suggesting it is a potential biomarker affecting uric acid levels in females.
Zhihan Yang, Zeng Zhang, Mohan Chen, Jin Hu, Yingqi Qiu, Shijia Lin, Xiaolu Zhou, Jiachao Zhang, Shuaiming Jiang   +8 more
wiley   +1 more source

Association between apolipoprotein E ε4 status and the risk of Alzheimer's disease: a meta-analysis. [PDF]

BMC Neurosci
Ren Z, Guan Z, Guan Q, Guan H, Guan H.
europepmc   +1 more source

Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease

Experimental biology and medicine, 2016
Therese S Salameh, E. Rhea, W. Banks, A. Hanson   +3 more
semanticscholar   +1 more source

Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes. [PDF]

, 1990
Donald Schouten, M.F. Kleinherenbrink-Stins, Anne-Marie Brouwer, D.L. Knook, Jan A. A. M. Kamps, Johan Kuiper, T J van Berkel   +6 more
openalex   +1 more source

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis, Elijah J. Weber, Cara Nelson, Ann R. Qin, Timothy R. Watkins, Ahmed A. Othman   +5 more
wiley   +1 more source

No effect of apolipoprotein E polymorphism on MRI brain activity during movie watching. [PDF]

Brain Neurosci Adv
Raykov PP, Daly J, Fisher SE, Eising E, Geerligs L, Bird CM.   +5 more
europepmc   +1 more source

Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

, 1990
Robert Kowal, Joachim Herz, Karl H. Weisgraber, R W Mahley, M S Brown, J L Goldstein   +5 more
openalex   +1 more source